ArticleClinical ophthalmology (Auckland, N.Z.)2026
Femtosecond Laser-Assisted Cataract Surgery versus Conventional Phacoemulsification Combined with Vitrectomy for Cataract Complicated with Fundus Disease: Superior Efficacy in Patients with Vitreous Opacity and Cost-Effectiveness Analysis.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To compare the efficacy of femtosecond laser assisted cataract surgery (FLACS) combined with pars plana vitrectomy (PPV) and conventional phacoemulsification surgery (CPS) combined with PPV in the treatment of cataract patients with fundus diseases. Methods: A retrospective analysis was conducted on 379 affected eyes from Shanghai Aier Eye Hospital from 01/02/2022 to 01/02/2025, divided into group A (n=182, 48%, FLACS+PPV) and group B (n=197, 52%, CPS+PPV), to compare surgical costs, best corrected visual acuity (BCVA), complications, and surgical time. Results: Postoperative visual acuity improved significantly in both groups (all P < 0.0001). For vitreous opacity (VO) patients, the BCVA improvement in group A (0.34±0.51) was significantly better than that in group B (0.15±0.52, P=0.03), with a shorter surgical time (45.22±8.15 vs 52.72±7.17 min, P < 0.0001) and lower complication rate (7.14% vs 11.68%). Overall, group A had a shorter surgical time (47.75±10.06 vs 59.22±11.6 min, P < 0.0001) and better postoperative BCVA (0.36±0.45 vs 0.49±0.48, P=0.0001) than group B, but higher surgical costs (21,600±9180 vs 15,399±2996 yuan, P < 0.0001). Conclusion: FLACS+PPV has excellent therapeutic effects but is expensive, while CPS+PPV has a high cost-effectiveness, and clinical selection should be based on the patient's condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.